HighMark Wealth Management’s Neuronetics STIM Stock Holding History

HighMark Wealth Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,000	Closed	-$16K	–	553
2022 Q2	$16K	Hold	5,000	–	–	0.01%	191
2022 Q1	$15K	Sell	5,000 -4,000	-44%	-$13.5K	0.01%	208
2021 Q4	$40K	Sell	9,000 -9,565	-52%	-$46.8K	0.03%	133
2021 Q3	$122K	Buy	18,565 +12,527	+207%	+$120K	0.09%	68
2021 Q2	$97K	Buy	6,038 +5,736	+1,899%	+$79.3K	0.07%	77
2021 Q1	$4K	Buy	+302	New	+$4.63K	﹤0.01%	373

Other funds holding STIM

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HighMark Wealth Management's STIM Position: Q3 2022 in Review

HighMark Wealth Management sold out of Neuronetics (STIM) in Q3 2022, closing a stake of 5,000 shares — an estimated $16K sold.

HighMark Wealth Management first reported a position in STIM in Q1 2021 and held it in 6 quarters. The position peaked at $122K in Q3 2021. 76 funds tracked by Wall St. Rank hold STIM as of Q3 2022.

HighMark Wealth Management reported no remaining Neuronetics position as of Q3 2022 after selling out during the quarter.
HighMark Wealth Management sold 5,000 Neuronetics shares in Q3 2022, an estimated $16K.
HighMark Wealth Management first reported a position in Neuronetics in Q1 2021 and held it in 6 quarters.
HighMark Wealth Management's Neuronetics position peaked at $122K in Q3 2021.
76 funds tracked by Wall St. Rank held Neuronetics as of Q3 2022.

Based on HighMark Wealth Management's 13F filing for Q3 2022, filed 21 Oct 2022.